337 related articles for article (PubMed ID: 24572043)
1. Enhanced chemoprophylactic and clinical efficacy of albendazole formulated as solid dispersions in experimental cystic echinococcosis.
Pensel PE; Castro S; Allemandi D; Bruni SS; Palma SD; Elissondo MC
Vet Parasitol; 2014 Jun; 203(1-2):80-6. PubMed ID: 24572043
[TBL] [Abstract][Full Text] [Related]
2. Chemoprophylactic and therapeutic efficacy of thymol in murine cystic echinococcosis.
Maggiore M; Pensel PE; Denegri G; Elissondo MC
Parasitol Int; 2015 Oct; 64(5):435-40. PubMed ID: 26096310
[TBL] [Abstract][Full Text] [Related]
3. Albendazole-lipid nanocapsules: Optimization, characterization and chemoprophylactic efficacy in mice infected with Echinococcus granulosus.
Ullio Gamboa GV; Pensel PE; Elissondo MC; Sanchez Bruni SF; Benoit JP; Palma SD; Allemandi DA
Exp Parasitol; 2019 Mar; 198():79-86. PubMed ID: 30769018
[TBL] [Abstract][Full Text] [Related]
4. In vivo evaluation of the efficacy of albendazole sulfoxide and albendazole sulfoxide loaded solid lipid nanoparticles against hydatid cyst.
Ahmadnia S; Moazeni M; Mohammadi-Samani S; Oryan A
Exp Parasitol; 2013 Oct; 135(2):314-9. PubMed ID: 23912040
[TBL] [Abstract][Full Text] [Related]
5. Experimental cystic echinococcosis therapy: In vitro and in vivo combined 5-fluorouracil/albendazole treatment.
Pensel PE; Elissondo N; Gambino G; Gamboa GU; Benoit JP; Elissondo MC
Vet Parasitol; 2017 Oct; 245():62-70. PubMed ID: 28969840
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo effects of chitosan-praziquantel and chitosan-albendazole nanoparticles on Echinococcus granulosus Metacestodes.
Torabi N; Dobakhti F; Faghihzadeh S; Haniloo A
Parasitol Res; 2018 Jul; 117(7):2015-2023. PubMed ID: 29616349
[TBL] [Abstract][Full Text] [Related]
7. Albendazole solid dispersions against alveolar echinococcosis: a pharmacotechnical strategy to improve the efficacy of the drug.
Fabbri J; Pensel PE; Albani CM; Lopez LM; Simonazzi A; Bermudez JM; Palma SD; Elissondo MC
Parasitology; 2020 Aug; 147(9):1026-1031. PubMed ID: 32338226
[TBL] [Abstract][Full Text] [Related]
8. Effects of benzimidazole compounds on mice infected with secondary cysts of Echinococcus granulosus.
Xiao SH; Yang YQ; You JQ; Shen BG; Jiao W; Chai JJ
Chin Med J (Engl); 1994 Jul; 107(7):521-32. PubMed ID: 7956500
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of ursolic acid against Echinococcus granulosus in vitro and in a murine infection model.
Yin J; Liu C; Shen Y; Zhang H; Cao J
Parasit Vectors; 2018 Jan; 11(1):58. PubMed ID: 29368624
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of albendazole chitosan microspheres against Echinococcus granulosus infection in mice].
Liang W; Wang XC; Wu XW; Zhang SJ; Sun H; Ma X; Peng XY
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2014 Jun; 32(3):188-92. PubMed ID: 25223052
[TBL] [Abstract][Full Text] [Related]
11. Could beta-myrcene be an alternative to albendazole for the treatment of experimental cystic echinococcosis?
Fabbri J; Maggiore MA; Pensel PE; Albani CM; Denegri GM; Elissondo MC
Acta Trop; 2018 Nov; 187():5-12. PubMed ID: 30040945
[TBL] [Abstract][Full Text] [Related]
12. [Effect of mebendazole, albendazole and albendazole sulfoxide on glycogen contents of Echinococcus granulosus cysts in infected mice].
Xiao SH; Yang YQ; Guo HF; Zhang CW; Jiao PY; You JQ; Jiao W
Zhongguo Yao Li Xue Bao; 1990 Nov; 11(6):546-9. PubMed ID: 2130620
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the efficacy of albendazole sulfoxide (ABZ-SO)-loaded chitosan-PLGA nanoparticles in the treatment of cystic echinococcosis in laboratory mice.
Darvishi MM; Moazeni M; Alizadeh M; Abedi M; Tamaddon AM
Parasitol Res; 2020 Dec; 119(12):4233-4241. PubMed ID: 32996050
[TBL] [Abstract][Full Text] [Related]
14. Intra-cystic concentrations of albendazole-sulphoxide in human cystic echinococcosis: a systematic review and analysis of individual patient data.
Lötsch F; Naderer J; Skuhala T; Groger M; Auer H; Kaczirek K; Waneck F; Ramharter M
Parasitol Res; 2016 Aug; 115(8):2995-3001. PubMed ID: 27085708
[TBL] [Abstract][Full Text] [Related]
15. Albendazole nanocrystals in experimental alveolar echinococcosis: Enhanced chemoprophylactic and clinical efficacy in infected mice.
Pensel P; Paredes A; Albani CM; Allemandi D; Sanchez Bruni S; Palma SD; Elissondo MC
Vet Parasitol; 2018 Feb; 251():78-84. PubMed ID: 29426481
[TBL] [Abstract][Full Text] [Related]
16. Anthelminthic treatment: an adjuvant therapeutic strategy against Echinococcus granulosus.
Stamatakos M; Sargedi C; Stefanaki Ch; Safioleas C; Matthaiopoulou I; Safioleas M
Parasitol Int; 2009 Jun; 58(2):115-20. PubMed ID: 19272345
[TBL] [Abstract][Full Text] [Related]
17. Scolicidal and apoptotic activities of albendazole sulfoxide and albendazole sulfoxide-loaded PLGA-PEG as a novel nanopolymeric particle against Echinococcus granulosus protoscoleces.
Naseri M; Akbarzadeh A; Spotin A; Akbari NA; Mahami-Oskouei M; Ahmadpour E
Parasitol Res; 2016 Dec; 115(12):4595-4603. PubMed ID: 27623699
[TBL] [Abstract][Full Text] [Related]
18. Benzimidazoles for the treatment of cystic and alveolar echinococcosis: what is the consensus?
Vuitton DA
Expert Rev Anti Infect Ther; 2009 Mar; 7(2):145-9. PubMed ID: 19254162
[No Abstract] [Full Text] [Related]
19. A pharmacology-based comparison of the activity of albendazole and flubendazole against Echinococcus granulosus metacestode in sheep.
Ceballos L; Virkel G; Elissondo C; Canton C; Canevari J; Murno G; Denegri G; Lanusse C; Alvarez L
Acta Trop; 2013 Sep; 127(3):216-25. PubMed ID: 23692888
[TBL] [Abstract][Full Text] [Related]
20. Albendazole treatment in cystic echinococcosis: pharmacokinetics and clinical efficacy of two different aqueous formulations.
Ceballos L; Elissondo C; Moreno L; Dopchiz M; Sánchez Bruni S; Denegri G; Alvarez L; Lanusse C
Parasitol Res; 2008 Jul; 103(2):355-62. PubMed ID: 18465143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
